Skip to main
HEB
HEB logo

Hemispherx Biopharma (HEB)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Hemispherx Biopharma (HEB) Stock

About Hemispherx Biopharma (HEB)

The full company name is Hemispherx Biopharma Inc.
Market cap$4.19M
Yesterday's volume23.53K
Revenue (TTM)
Avg. daily volume101.53K
EBITDA (TTM)
Open$1.45
Price / earnings ratio-0.07x
Yesterday's range$1.41 - $1.51
Debt / equity
52 week range$1.26 - $36
5 year debt / equity-3.97x
Beta (LTM)0.29x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

As of Dec 04, 2025, the market cap for HEB stock is $4.2M

The current P/E ratio for HEB stock is -0.07

The 52-week high for HEB stock is $36. The current HEB stock price $undefined is 100.00% below its 52-week high

The 52-week low for HEB stock is $1.26. The current HEB stock price $undefined has increased 100.00% from its 52-week low

No, the HEB stock does not pay dividends to its shareholders

How to buy HEB stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in HEB stock

    Navigate to the Explore page. Then, type HEB into the search bar. When you see HEB stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased HEB stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Buy Hemispherx Biopharma (HEB) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.